{"id":123290,"date":"2021-04-30T17:36:14","date_gmt":"2021-04-30T17:36:14","guid":{"rendered":"https:\/\/precoinnews.com\/?p=123290"},"modified":"2021-04-30T17:36:14","modified_gmt":"2021-04-30T17:36:14","slug":"who-expects-assessment-of-moderna-and-two-chinese-vaccines-by-end-of-next-week","status":"publish","type":"post","link":"https:\/\/precoinnews.com\/world-news\/who-expects-assessment-of-moderna-and-two-chinese-vaccines-by-end-of-next-week\/","title":{"rendered":"WHO expects assessment of Moderna and two Chinese vaccines by end of next week"},"content":{"rendered":"
GENEVA (REUTERS) – The World Health Organisation expects to release its assessments for emergency use listing of the two main Chinese vaccines for Covid-19 as well as the Moderna shot by the end of next week, WHO assistant director-general Mariangela Simao said on Friday (April 30).<\/p>\n
Simao said the WHO’s independent panel was assessing the Moderna vaccine and a vaccine from China’s Sinopharm on Friday and was due to look at China’s other main vaccine, made by Sinovac Biotech, next week.<\/p>\n
“So, by the beginning of next week or the end of next week we will have the final assessment of these three vaccines out,”she told a briefing.<\/p>\n
WHO emergency use listing is a signal to national regulators that a vaccine is safe and effective, and would allow those vaccines to be bought and distributed by Covax, the international programme to share vaccines for poor countries.<\/p>\n
Simao said it was important to have more vaccines available because of supply problems for other shots, including from India, a main source of vaccines for Covax\u00a0which has restricted exports because of a surge in domestic cases.<\/p>\n
If approved, China’s two vaccines would be the first developed in a non-Western country to receive the WHO’s backing.<\/p>\n
China has already deployed millions of doses of both its main vaccines at home and has exported them to many countries, particularly in Latin America, Asia and Africa.<\/p>\n
So far, the WHO has given emergency use listing to three shots against Covid-19, made by Pfizer, AstraZeneca and Johnson & Johnson.<\/p>\n